Paibel Aguayo-HIraldo

Assistant Professor /Clinical director Transplant and Cellular Therapy

University of Southern California

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paibel Aguayo-HIraldo is an Assistant Professor and Clinical Director of Transplant and Cellular Therapy at the University of Southern California, USA. His research focuses on acute graft-versus-host disease (GVHD), particularly the development of novel biomarkers and risk stratification models to predict treatment outcomes. Recent publications include studies on the MAGIC composite response and safety surveillance plans for cellular therapy clinical trials.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (9)

Hrishikesh Srinagesh

Stanford University

UNITED STATES

View details

Christopher Dandoy

department of pediatrics university of cincinnati college of medicine cincinnati ohio usa

UNITED STATES

View details

Najla El Jurdi

Assistant Professor

University of Minnesota

UNITED STATES

View details

Elizabeth Hexner

UNITED STATES

View details

Satiro De Oliveira

Associate Professor

UNITED STATES

View details

Michael Keller

Assistant Professor

George Washington University

UNITED STATES

View details

Carla Davis

Baylor College of Medicine Department of Pediatrics

UNITED STATES

View details

Saleh Bhar

Baylor College of Medicine

UNITED STATES

View details

Stephan Grupp

Section Chief, Cellular Therapy and Transplant

Children's Hospital of Philadelphia

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paibel Aguayo-HIraldo

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHD

A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation–associated TMA

Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD

Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD

A day 14 endpoint for acute GVHD clinical trials

Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival

Collaborators (9)

Hrishikesh Srinagesh

Christopher Dandoy

Najla El Jurdi

Elizabeth Hexner

Satiro De Oliveira

Michael Keller

Carla Davis

Saleh Bhar

Stephan Grupp

Make your next move.